Sodium-Glucose Co-Transporter 2 Inhibitors and the Risk of Venous Thromboembolism in Patients with Type 2 Diabetes: A Cohort Study
Niklas Schmedt, Dirk Enders, Jochen Walker, Edeltraut Garbe, Antonios Douros
Topics & Concepts
MedicineEmpagliflozinType 2 diabetesInternal medicineDapagliflozinCohortHazard ratioDiabetes mellitusIncidence (geometry)PopulationRate ratioCohort studyConfidence intervalEndocrinologyOpticsPhysicsEnvironmental healthDiabetes Treatment and ManagementPotassium and Related DisordersAtrial Fibrillation Management and Outcomes